Therapeutic Goods (Medicines Advisory Statements) Specification 2019
7Medicines advisory statements
Start here
Get a plain-English read of 7
Turn the raw legal text into a practical explanation grounded in Therapeutic Goods (Medicines Advisory Statements) Specification 2019.
7 Medicines advisory statements
(1) Subject to this section and section 8, the advisory statements mentioned in column 3 of the table in Schedule 1 to this instrument, are specified for the purposes of paragraph 3(5)(ca) of the Act in respect of a medicine in a prescribed class that contains the substance described in column 1 of the corresponding row and in the conditions set out in column 2.
(2) In addition, the advisory statements mentioned in Schedule 1, where varied or, if more than one such statement applies, combined to form a simple sentence on the label of a medicine in a prescribed class in a manner that does not change the intent of the advisory statement, are specified for the purposes of paragraph 3(5)(ca) of the Act.
Note: Unless otherwise specified in column 2 of the table in Schedule 1, the requirements only apply if the substance is included in the medicine as an active ingredient.